Company news

AstraZeneca PLC news in 2020

AstraZeneca PLC's news releases, calls and decks from 2020, newest first.

View company

AstraZeneca's COVID-19 vaccine authorised in UK

December 30, 2020

Lynparza approved in Japan for three cancers

December 29, 2020

Tagrisso approved in the US for early lung cancer

December 21, 2020

Update on US regulatory review of roxadustat

December 21, 2020

Imfinzi new dose receives positive EU CHMP opinion

December 15, 2020

Trastuzumab deruxtecan positive CHMP

December 14, 2020

Trixeo Aerosphere approved in the EU for COPD

December 14, 2020

AstraZeneca to acquire Alexion Pharmaceuticals Inc

December 14, 2020

Crestor to be divested to Grünenthal in Europe

December 1, 2020

Forxiga approved in Japan for heart failure

November 30, 2020

AZD1222 vaccine effective against COVID-19

November 23, 2020

Imfinzi new dosing approved in the US

November 20, 2020

Tezepelumab Phase III trial met primary endpoint

November 10, 2020

Calquence approved in the EU for CLL

November 9, 2020

Brilinta approved in the US in stroke

November 6, 2020

Lynparza approved in the EU for wider ovarian use

November 5, 2020

Lynparza approved in the EU for prostate cancer

November 5, 2020

Forxiga approved in the EU for heart failure

November 5, 2020

AZN: Year-to-date and Q3 2020 results

November 5, 2020

Atacand to be divested in more than 70 countries

October 30, 2020

Enhertu US Priority Review in gastric cancer

October 28, 2020

Forxiga CV outcomes benefit approved in China

October 28, 2020

Tagrisso adjuvant lung cancer US Priority Review

October 20, 2020

Trixeo Aerosphere receives positive CHMP opinion

October 19, 2020

Forxiga HF receives positive CHMP opinion

October 19, 2020

COVID-19 antibodies advance and get US funding

October 12, 2020

Farxiga granted US BTD in chronic kidney disease

October 2, 2020

Lynparza EU recommendation in prostate cancer

September 21, 2020

Tagrisso reduced early lung cancer brain recurrenc

September 21, 2020

Lynparza EU recommendation in ovarian cancer

September 21, 2020

AstraZeneca to list all US securities on Nasdaq

September 10, 2020

Fasenra PhIII OSTRO trial met co-primary endpoints

September 10, 2020

Imfinzi approved in EU for small cell lung cancer

September 1, 2020

Farxiga reduces CKD progression and risk of death

September 1, 2020

Ph I trial begins for COVID-19 monoclonal antibody

August 25, 2020

Imfinzi approved in Japan for SCLC

August 21, 2020

Imfinzi US Priority Review; four-week, fixed dose

August 18, 2020

AstraZeneca prices a $3bn bond issue

August 4, 2020

Tagrisso US BTD for EGFRm adjuvant lung cancer

July 30, 2020

AZN: H1 2020 results

July 30, 2020

Farxiga DAPA-CKD trial met all endpoints

July 28, 2020

Calquence receives positive CHMP opinion for CLL

July 27, 2020

Imfinzi recommended for EU approval in SCLC

July 27, 2020

AstraZeneca enters collaboration in oncology

July 27, 2020

Breztri Aerosphere approved in the US for COPD

July 24, 2020

COVID-19 vaccine Phase I/II showed immune response

July 20, 2020

Brilinta granted US FDA Priority Review for stroke

July 9, 2020

Lynparza approved in the EU for pancreatic cancer

July 8, 2020

Selumetinib granted Japan orphan drug designation

June 30, 2020

Agreement to Supply Europe with COVID-19 Vaccine

June 15, 2020

Older news releases →

Decks in 2020